Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferroptosis in SF3B1-mutant MDS
NCT05924074Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Percentage of cells undergoing ferroptosis. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT05924074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924074.